• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Phathom Pharmaceuticals Inc (NQ: PHAT )

    11.50 +0.22 (+1.95%)
    Streaming Delayed Price Updated: 11:16 AM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Phathom Pharmaceuticals Inc

    < Previous 1 2 3 4 Next >
    Ready for Quick Gains? 7 Top Short-Squeeze Stocks to Watch Now
    Each of the following seven heavily-shorted stocks may have what it takes to become one of the next big short squeeze stocks. 
    Via InvestorPlace
    Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
    Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right. 
    Via InvestorPlace
    The 3 Best Healthcare Stocks to Buy in May 2024
    Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now. 
    Via InvestorPlace
    PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
    PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
    PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Preview: Phathom Pharmaceuticals's Earnings
    Via Benzinga
    Recap: Phathom Pharmaceuticals Q3 Earnings
    Via Benzinga
    Phathom Pharmaceuticals Resubmits FDA Application For Acid Blocker, Raises $131M Via Equity
      
    Via Benzinga
    Analyst Expectations for Phathom Pharmaceuticals's Future
    Via Benzinga
    Earnings Scheduled For March 7, 2024
    Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
    Via Benzinga
    Where Phathom Pharmaceuticals Stands With Analysts
    Via Benzinga
    Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    "Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales
    Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),  
    Via Benzinga
    Where Phathom Pharmaceuticals Stands With Analysts
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    What's Going On With Phathom Pharmaceuticals Stock?
    Phathom Pharmaceuticals Inc (NASDAQ: PHAT) shares are trading higher Monday after the company announced FDA approval of its reformulated vo 
    Via Benzinga
    Exposures Product Safety
    Cramer Likes This Industrial Stock: A 'Well-Run' Company Doing 'A Lot Of Good Things'
    On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended not buying ChargePoint Holdings, Inc. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
    Via Benzinga
    3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
    One of the safest sectors on the market is biotech. Here are three cheap biotech stocks to buy that are good options for investors. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
    Via Benzinga
    Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks
    Although US stocks closed mixed on Tuesday, there were a few notable insider trades. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 469 companies hit new 52-week lows. 
    Via Benzinga
    $14M Bet On This Technology Stock? Check Out These 4 Stocks Insiders Are Buying
    Although US stocks closed mixed on Tuesday, there were a few notable insider trades. 
    Via Benzinga
    Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursday. SeqLL recently announced the establishment of a two-year Cooperative Research and Development... 
    Via Benzinga
    One Analyst Is Bullish While Another Sees Overhang On Phathom Pharma Stock After Two Rejection Letters
    FDA issued two Complete Response Letters to Phathom Pharmaceuticals Inc's (NASDAQ: PHAT) vonoprazan marketing application for the erosive esophagitis (EE) indication and H. pylori (HP) indication... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.